trinamiX Launches a Mobile NIR Spectroscopy Solution
The measurement device comes with an infrared semiconductor to examine the molecular structure of materials in a wavelength range up to 2,5 µm for factory and lab applications.
trinamiX GmbH, a subsidiary of BASF SE, announced on March 23, 2020 that it is launching a mobile, handheld near-infrared (NIR) spectroscopy solution for factory and laboratory applications.
The measurement device comes equipped with an infrared semiconductor to efficiently examine the molecular structure of materials in a wavelength range up to 2,5 µm, along with mobile and robust hardware, precise data and material analytics, and molecular and chemical capabilities.
Device capabilities include inbound control, quality checks, on-the-field analytics, and material sorting and identification. The company states that trinamiX production capabilities are suited for high-volume production that runs all the way up to consumer electronics-level supply demands.
Source: trinamiX
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
